Altamira Therapeutics Ltd. Adjustments For Decrease Increase In Inventories
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Decrease Increase In Inventories of -CHF 319.82 thousand for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-04-22.
Financial Statements › Notes › Inventory
ifrs-full:AdjustmentsForDecreaseIncreaseInInventories · last filed 2025-04-30
CHF
| Period end | Adjustments For Decrease Increase In Inventories 6 month | Adjustments For Decrease Increase In Inventories 12 month |
|---|---|---|
| 2023-12-31 | -319.82K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | -258.86K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 827.58K CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 692.86K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | -839.22K CHF 20-F/A · filed 2024-04-22 | |
| 2021-06-30 | -196.41K CHF 6-K/A · filed 2023-08-21 |
USD
| Period end | Adjustments For Decrease Increase In Inventories 6 month | Adjustments For Decrease Increase In Inventories 12 month |
|---|---|---|
| 2023-12-31 | -$355.95K 20-F · filed 2025-04-30 | |
| 2023-06-30 | -$283.87K 6-K · filed 2024-09-24 | |
| 2022-12-31 | $866.57K 20-F · filed 2025-04-30 |